Three Chinese companies are collaborating with Fidson Healthcare to set up a plant in Nigeria to make HIV drugs, for example, while the EU is providing grants to Rwanda to support local pharma efforts
Let's not think of semaglutide as the end-all solution to weight loss (because, honestly, it's not)
Potential Side Effects Semaglutide may cause a range of side effects, from mild to severe
Arizona IV Medics stands out as a trusted option in Phoenix, known for its commitment to high-quality care and patient satisfaction
Key Highlights OPGx-BEST1 targets BEST1-associated inherited retinal diseases, including BVMD and ARB AAV-based gene therapy approach designed to deliver a functional BEST1 gene directly to retinal pigment epithelium cells Five participants enrolled in Cohort 1, including three with BVMD and two with ARB Four participants have been dosed, with the fifth scheduled for dosing this month Dominant BEST disease participants underwent in vitro confirmation to assess whether their mutations are amenable to gene augmentation Early sentinel participant data showed positive tolerability and biological activity after subretinal administration Three-month topline Cohort 1 data expected in September 2026 For BEST1-associated diseases, careful patient selection, mutation-specific validation, and multi-endpoint retinal assessments may be key to advancing gene augmentation strategies
PlexusDx Weight Management Protocols build follow-up touchpoints into the protocol cadence so you stay compliant with state oversight rules and your clinician can adjust dose, formulation, or protocol as your response data accumulates
